Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho) - PubMed (original) (raw)
. 1997 Sep;11(9):1447-52.
doi: 10.1038/sj.leu.2400756.
T Naoe, S Yokota, M Nakao, S Minami, K Kuriyama, A Takeshita, K Saito, S Hasegawa, S Shimodaira, J Tamura, C Shimazaki, K Matsue, H Kobayashi, N Arima, R Suzuki, H Morishita, H Saito, R Ueda, R Ohno
Affiliations
- PMID: 9305596
- DOI: 10.1038/sj.leu.2400756
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)
H Kiyoi et al. Leukemia. 1997 Sep.
Abstract
FLT3 is a member of receptor tyrosine kinases expressed in leukemia cells, as well as in hematopoietic stem cells. Recently, a somatic alteration of the FLT3 gene was found in acute myeloid leukemia, as an internal tandem duplication (FLT3/ITD) which caused elongation of the juxtamembrane (JM) domain of FLT3. Here we characterized the FLT3/ITD and investigated its clinical significance in acute promyelocytic leukemia (APL). Seventy-four newly diagnosed patients with APL, who were treated with the same protocol in a multi-institutional study, were studied for the FLT3/ITD. Genomic and message sequences of the FLT3 gene were amplified by means of polymerase chain reaction (PCR), and elongated PCR products were sequenced. Fifteen patients (20.3%) had FLT3/ITD, all of which were transcribed in frame. Location of the duplicated fragments (six to 30 amino acids) varied from patient to patient. However, they always contained either Y591 or Y599, but the tyrosine kinase domain was not significantly affected. This finding implied that signal transduction of FLT3 is amplified by the duplication. Clinically, the presence of FLT3/ITD was related to high peripheral white blood cell counts as well as peripheral leukemia cell counts (P < 0.0001), high LDH level (P = 0.04), and low fibrinogen concentration (P = 0.04). These data suggest that FLT3/ITD plays a significant role in progression of APL.
Similar articles
- Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.
Shih LY, Kuo MC, Liang DC, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Lai CL. Shih LY, et al. Cancer. 2003 Sep 15;98(6):1206-16. doi: 10.1002/cncr.11636. Cancer. 2003. PMID: 12973844 - Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
Callens C, Chevret S, Cayuela JM, Cassinat B, Raffoux E, de Botton S, Thomas X, Guerci A, Fegueux N, Pigneux A, Stoppa AM, Lamy T, Rigal-Huguet F, Vekhoff A, Meyer-Monard S, Ferrand A, Sanz M, Chomienne C, Fenaux P, Dombret H; European APL Group. Callens C, et al. Leukemia. 2005 Jul;19(7):1153-60. doi: 10.1038/sj.leu.2403790. Leukemia. 2005. PMID: 15889156 - Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
Lucena-Araujo AR, Kim HT, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille Mde L, Chiattone CS, Lima AS, Ruiz-Argüelles G, Undurraga MS, Martinez L, Kwaan HC, Gallagher R, Niemeyer CM, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM. Lucena-Araujo AR, et al. Ann Hematol. 2014 Dec;93(12):2001-10. doi: 10.1007/s00277-014-2142-9. Epub 2014 Jul 2. Ann Hematol. 2014. PMID: 24981688 - FLT3 in human hematologic malignancies.
Kiyoi H, Naoe T. Kiyoi H, et al. Leuk Lymphoma. 2002 Aug;43(8):1541-7. doi: 10.1080/1042819021000002866. Leuk Lymphoma. 2002. PMID: 12400596 Review. - Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review.
Beitinjaneh A, Jang S, Roukoz H, Majhail NS. Beitinjaneh A, et al. Leuk Res. 2010 Jul;34(7):831-6. doi: 10.1016/j.leukres.2010.01.001. Epub 2010 Jan 21. Leuk Res. 2010. PMID: 20096459 Review.
Cited by
- Early Prediction and Streamline of Nucleophosmin Mutation Status in Acute Myeloid Leukemia Using Cup-Like Nuclear Morphology.
Jakovic L, Djordjevic V, Kraguljac Kurtovic N, Virijevic M, Mitrovic M, Trajkovic L, Vidovic A, Bogdanovic A. Jakovic L, et al. Medicina (Kaunas). 2024 Sep 4;60(9):1443. doi: 10.3390/medicina60091443. Medicina (Kaunas). 2024. PMID: 39336484 Free PMC article. - Can pharmacogenetics impact the therapeutic effect of cytarabine and anthracyclines in adult acute myeloid leukaemia patients?: A Serbian experience.
Pravdić Z, Suvajdžić-Vuković N, Virijević M, Mitrović M, Pantić N, Sabljić N, Pavlović Đ, Marjanović I, Bukumirić Z, Vidović A, Jaković L, Pavlović S, Gašić V. Pravdić Z, et al. J Med Biochem. 2024 Jun 15;43(4):545-555. doi: 10.5937/jomb0-47459. J Med Biochem. 2024. PMID: 39139169 Free PMC article. - Identification of a novel mutation of the FLT3 gene located on the juxtamembrane domain from acute myeloid leukemia patients.
Arwanih EY, Rinaldi I, Wanandi SI, Louisa M. Arwanih EY, et al. Mol Biol Rep. 2024 Jul 29;51(1):867. doi: 10.1007/s11033-024-09790-1. Mol Biol Rep. 2024. PMID: 39073493 - Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib.
Wang P, Zhang Y, Xiang R, Yang J, Xu Y, Deng T, Zhou W, Wang C, Xiao X, Wang S. Wang P, et al. Cancer Res. 2024 Mar 15;84(6):905-918. doi: 10.1158/0008-5472.CAN-23-1534. Cancer Res. 2024. PMID: 38231480 Free PMC article. - Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
Gutierrez-Camino A, Richer C, Ouimet M, Fuchs C, Langlois S, Khater F, Caron M, Beaulieu P, St-Onge P, Bataille AR, Sinnett D. Gutierrez-Camino A, et al. Br J Cancer. 2024 Feb;130(2):317-326. doi: 10.1038/s41416-023-02511-8. Epub 2023 Dec 4. Br J Cancer. 2024. PMID: 38049555 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous